Unresectable Hepatocellular Carcinoma Clinical Trials in Chengdu, Sichuan
3 recruitingChengdu, Sichuan, China
Showing 1–3 of 3 trials
Recruiting
Phase 3
TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma
Unresectable Hepatocellular CarcinomaApatinibCamrelizumab+1 more
Guohui Xu101 enrolled1 locationNCT06485466
Recruiting
Phase 1Phase 2
A Multicenter Clinical Study of Combined Therapy for Unresectable Hepatocellular Carcinoma
Unresectable Hepatocellular Carcinoma
West China Hospital33 enrolled1 locationNCT07482059
Recruiting
Phase 3
Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere
Unresectable Hepatocellular Carcinoma
Chengdu New Radiomedicine Technology Co. LTD.108 enrolled11 locationsNCT06900543